Harvard Bioscience, Inc. (OQ:HBIO)

Business Focus: Advanced Medical Equipment & Technology

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for HBIO within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 23rd, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jan 3/20 Jan 2/20 Loewald Thomas W Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 20,700  
Jan 3/20 Jan 2/20 Kennedy John F Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 24,200  
Jan 3/20 Jan 1/20 Green James W Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -32,959 $3.05
Nov 13/19 Nov 13/19 Loy Bertrand Direct Ownership Common Stock P - Open market or private purchase 6,100 $2.52
Nov 13/19 Nov 12/19 Loy Bertrand Direct Ownership Common Stock P - Open market or private purchase 10,579 $2.51
Nov 13/19 Nov 11/19 Loy Bertrand Direct Ownership Common Stock P - Open market or private purchase 12,855 $2.59
Nov 13/19 Nov 11/19 Green James W Indirect Ownership Common Stock P - Open market or private purchase 10,000 $2.61
Nov 13/19 Nov 8/19 Loy Bertrand Direct Ownership Common Stock P - Open market or private purchase 6,616 $2.64
Dec 2/19 Nov 1/19 Edrick Alan I Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 600  
Nov 6/19 Nov 1/19 Olson Kenneth Fletcher Direct Ownership Stock option (right to buy) A - Grant, award or other under Rule 16b-3(d) 37,037  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for HBIO within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 23rd, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jan 3/20 Jan 1/20 Green James W Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -32,959 $3.05
Jan 3/20 Jan 2/20 Loewald Thomas W Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 20,700  
Jan 3/20 Jan 2/20 Kennedy John F Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 24,200  
Dec 2/19 Nov 1/19 Edrick Alan I Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 600  
Nov 13/19 Nov 13/19 Loy Bertrand Direct Ownership Common Stock P - Open market or private purchase 6,100 $2.52
Nov 13/19 Nov 12/19 Loy Bertrand Direct Ownership Common Stock P - Open market or private purchase 10,579 $2.51
Nov 13/19 Nov 11/19 Loy Bertrand Direct Ownership Common Stock P - Open market or private purchase 12,855 $2.59
Nov 13/19 Nov 8/19 Loy Bertrand Direct Ownership Common Stock P - Open market or private purchase 6,616 $2.64
Nov 13/19 Nov 11/19 Green James W Indirect Ownership Common Stock P - Open market or private purchase 10,000 $2.61
Nov 6/19 Nov 1/19 Olson Kenneth Fletcher Direct Ownership Stock option (right to buy) A - Grant, award or other under Rule 16b-3(d) 37,037  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $HBIO

Competitors

Competitors with Recent Insider Filings
Edwards Lifesciences (N:EW)
Intuitive Surgical (OQ:ISRG)
Danaher (N:DHR)